Research guide

GHRP-2

Pralmorelin · Growth hormone-releasing peptide 2

Also called pralmorelin, a peptide studied for its ability to stimulate growth-hormone release.

Compare
Product statusUnapproved / RUO
Development snapshotRUO

How it works, simply

It activates the growth-hormone secretagogue receptor.

What the evidence tells us

A diagnostic or short-term hormone response is different from evidence for long-term enhancement use.

Watch with PEP 7

A short introduction; the sources and limitations remain important.

Open video guide

Video guides are coming soon.

Risks and open questions

This guide does not establish a safe dose, interaction profile or long-term safety for self-use. Effects reported for one route or formulation may not apply to another.

Research and education only. PepGuide does not recommend medicines, doses or protocols.

Technical details and study context

Mechanism: Activates the growth hormone secretagogue receptor and can produce acute growth-hormone responses.

Sponsor or developer: No approved-product sponsor

Studied or labeled topics: Growth hormone claims, Body-composition claims

Commercial blend names and research vials do not inherit a medicine’s approval or manufacturing controls.

Sources and review dates

Product labels and further research

These directories help locate records. They are not individual studies supporting every statement.

Readability updated October 10, 2026. Evidence review: October 10, 2026 (FDA safety context only). A wording update is not a new clinical review.